|

miRNA to Guide Appropriate Intervention of Small Testis Masses

RECRUITINGSponsored by University Health Network, Toronto
Actively Recruiting
SponsorUniversity Health Network, Toronto
Started2023-07-12
Est. completion2027-02
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted

Summary

This study aims to determine, for the first time, if miRNA-371a-3p can be used as an accurate biomarker to identify which small (≤ 2cm) testicular masses are malignant and aid in clinical decision-making to offer surgery or surveillance. We propose a retrospective exploration of banked serum, plasma and semen specimens of men with small testis masses and a prospective biomarker-based intervention trial to validate miR-371a-3p performance.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* • Small testicular mass/masses ≤ 2cm

  * Patients with serum tumour marker elevation are eligible only if they are considered for surgical treatment, or if markers are felt to be falsely elevated by the physician team
  * If the patient previously had chemotherapy, the mass must first have appeared only after the treatment completed
  * The patient is at least 18 years of age
  * Ability to understand and comply with the requirements of the study
  * Ability to understand and willingness to sign a written informed consent

Exclusion Criteria:

* • Patients with testicular tumours \> 2 cm

  * Metastatic disease
  * Patients in reduced general condition, with uncontrolled intercurrent illnesses, or with life-threatening disease
  * Patients with psychiatric illnesses that would limit compliance with study requirements
  * Clinical decision is made by the multidisciplinary team that patient is not suitable for surveillance

Conditions2

CancerTestis Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.